Product Images Tranexamic Acid

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Tranexamic Acid NDC 51662-1532 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Case Labeling - 51662 1532 3 Case Labeling

Case Labeling - 51662 1532 3 Case Labeling

TRANEXAMIC ACID INJECTION is a medication that is to be used intravenously only. Each 10ml vial contains USP, 1,000mg of tranexamic acid. A box of 10 vials is available for use. The usual dosage required can be referred in the accompanying USP prescribing information. Store this medication at controlled room temperature (20° to 25°C) and discard any unused portion. The manufacturer of this injection is HF Acquistion Co., LLC located in Mukilteo, WA 98275. The medication has been assigned the Original NF6 NDC number 55150-188-10 and is only available with a prescription.*

DESCRIPTION - DESCRIPTION

DESCRIPTION - DESCRIPTION

DOSAGE - DOSAGE

DOSAGE - DOSAGE

The table shows the recommended Tranexamic Acid Injection Intravenous Dosage for patients with varying degrees of renal impairment based on their serum creatinine levels. Dosages range from 10 mg/kg twice daily for patients with serum creatinine levels of 2.83 (120 to 250 micromol/L) to 5 mg/kg every 24 hours for patients with serum creatinine levels above 5.66 (>500 micromol/L).*

POUCH LABELING - POUCH

POUCH LABELING - POUCH

TRANEXAMIC ACID INJECTION, USP is a medication that comes in a 10mL vial containing 1000mg/10mL or 100mg/mL. It is intended for intravenous use only and should be stored at 20-25°C. The appropriate dosage should be determined based on the accompanying fibrin formation data. Any medication that has not been used should be discarded. This specific product was manufactured by HF Acquistion in Mukilteo, Washington and is only available with a prescription.*

SEERIALIZED LABELING - Serialized Labeling

SEERIALIZED LABELING - Serialized Labeling

This is a product identifier for an item called "12345" that requires the user to refer to the manufacturer's package insert for further information. It was distributed by HF Acquisition Co., LLC in Mukilteo, WA. The other numbers are likely internal codes that do not provide any useful information.*

SERIALIZED VIAL LABELING - Serialized Vial Labeling

SERIALIZED VIAL LABELING - Serialized Vial Labeling

Vial Labeling - VIAL LABEL

Vial Labeling - VIAL LABEL

AUROMEDICS is a pharmaceutical company that produces Tranexamic Acid Injection, which is only for intravenous use, in 1,000 mg per 10 mL (100 mg / mL), stored at a temperature of 20°-25°C, and in a sterile single-dose vial of 10 mL. The tranexamic acid USP 100 mg is present in every mL of the sterile aqueous solution for intravenous injection. Prescribing information should be referred to for the usual dosage. The product is distributed by AuroMedics Pharma LLC and manufactured in India.*

Vial - Vial Label Update

Vial - Vial Label Update

This is a description of a medication called Tranexamic Acid Injection, USP, by the pharmaceutical company AuroMedics. The medication is intended for intravenous use only and comes in a 10 mL sterile single-dose vial. Each mL of the sterile aqueous solution contains tranexamic acid USP 100mg. The medication should be stored at room temperature and discarded if any portion is unused. Specific dosages should be determined and overseen by a prescribing healthcare provider.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.